Microfracture- and Xeno-Matrix-Induced Chondrogenesis for Treatment of Focal Traumatic Cartilage Defects of the Knee: Age-Based Mid-Term Results.
Francesco AllegraAurelio PicchiMarco RatanoStefano GuminaAndrea FidanzaGiandomenico LogroscinoPublished in: Healthcare (Basel, Switzerland) (2023)
The aim of this study was to investigate clinical and instrumental outcomes of the autologous matrix-induced chondrogenesis (AMIC) technique for the treatment of isolated traumatic condyle and femoropatellar cartilage lesions. A total of 25 patients (12 males, 13 females, mean age 47.3 years) treated between 2018 and 2021 were retrospectively reviewed and subdivided into two groups based on age (Group A, age < 45 years; Group B, age > 45 years). A clinical evaluation was performed using the International Knee Documentation Committee (IKDC), Lysholm score and Visual Analogue Score (VAS). Cartilage regeneration was evaluated via magnetic resonance (1.5 Tesla) and classified according to a Magnetic resonance Observation of CArtilage Repair Tissue (MOCART) scoring system. At a minimum follow-up of 2 years, Group A patients obtained greater instrumental results in comparison to group B: in fact, the MOCART score was statistically significantly correlated with IKDC (r = 0.223) ( p < 0.001) exclusively in group A. Nevertheless, a significant improvement in clinical functionality was shown in Group B ( p < 0.001), demonstrating that this technique is safe, reproducible and capable of offering satisfactory clinical results regardless of age.
Keyphrases
- magnetic resonance
- end stage renal disease
- newly diagnosed
- spinal cord injury
- ejection fraction
- chronic kidney disease
- clinical evaluation
- total knee arthroplasty
- prognostic factors
- extracellular matrix
- high glucose
- peritoneal dialysis
- computed tomography
- diabetic rats
- oxidative stress
- type diabetes
- mesenchymal stem cells
- cell therapy